Hepatotoxicity associated to synthetic cannabinoids use

R. Solimini, F. P. Busardò, M. C. Rotolo, Serafino Ricci, L. Mastrobattista, C. Mortali, S. Graziano, M. Pellegrini, N. M. Di Luca, Ilaria Palmi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Synthetic cannabinoids (SCs) are psychotropic compounds, chemically created in laboratory to mimic cannabinergic brain activity of delta-9 tetrahydrocannabinol.The consumption of these compounds for recreational purposes can lead to a variety of adverse effects on health including overdose and deaths. Increasingly popular as substances of abuse since the 2000s, SCs were produced initially to bind and study cannabinoid receptors (they also can be called synthetic cannabimimetics) failing in eliminating the psychoactive effects. Currently, SCs are misused by students and young adults as "natural products" because of their herbal aspect. Actually, these apparently innocuous recreational substances hide toxic effects to health. Reported side effects are cardiovascular, gastrointestinal, neurological, renal, metabolic, ophthalmologic, pulmonary and psychoactive including dependence and withdrawal. A few cases of SCs ingestion have also been associated with liver failure.We herein review the recent literature on the SCs toxicity with particular attention to liver damage aspects.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalEuropean Review for Medical and Pharmacological Sciences
Volume21
Issue number1
Publication statusPublished - Jan 1 2017

Fingerprint

Cannabinoids
Cannabinoid Receptors
Dronabinol
Poisons
Liver Failure
Health
Biological Products
Substance-Related Disorders
Young Adult
Eating
Students
Kidney
Lung
Liver
Brain

Keywords

  • Hepatotoxicity
  • Illicit use
  • Synthetic cannabinoids

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Hepatotoxicity associated to synthetic cannabinoids use. / Solimini, R.; Busardò, F. P.; Rotolo, M. C.; Ricci, Serafino; Mastrobattista, L.; Mortali, C.; Graziano, S.; Pellegrini, M.; Di Luca, N. M.; Palmi, Ilaria.

In: European Review for Medical and Pharmacological Sciences, Vol. 21, No. 1, 01.01.2017, p. 1-6.

Research output: Contribution to journalArticle

@article{a6c9f53fa5f04c789366b1ff09ae3d71,
title = "Hepatotoxicity associated to synthetic cannabinoids use",
abstract = "Synthetic cannabinoids (SCs) are psychotropic compounds, chemically created in laboratory to mimic cannabinergic brain activity of delta-9 tetrahydrocannabinol.The consumption of these compounds for recreational purposes can lead to a variety of adverse effects on health including overdose and deaths. Increasingly popular as substances of abuse since the 2000s, SCs were produced initially to bind and study cannabinoid receptors (they also can be called synthetic cannabimimetics) failing in eliminating the psychoactive effects. Currently, SCs are misused by students and young adults as {"}natural products{"} because of their herbal aspect. Actually, these apparently innocuous recreational substances hide toxic effects to health. Reported side effects are cardiovascular, gastrointestinal, neurological, renal, metabolic, ophthalmologic, pulmonary and psychoactive including dependence and withdrawal. A few cases of SCs ingestion have also been associated with liver failure.We herein review the recent literature on the SCs toxicity with particular attention to liver damage aspects.",
keywords = "Hepatotoxicity, Illicit use, Synthetic cannabinoids",
author = "R. Solimini and Busard{\`o}, {F. P.} and Rotolo, {M. C.} and Serafino Ricci and L. Mastrobattista and C. Mortali and S. Graziano and M. Pellegrini and {Di Luca}, {N. M.} and Ilaria Palmi",
year = "2017",
month = "1",
day = "1",
language = "English",
volume = "21",
pages = "1--6",
journal = "European Review for Medical and Pharmacological Sciences",
issn = "1128-3602",
publisher = "Verduci Editore",
number = "1",

}

TY - JOUR

T1 - Hepatotoxicity associated to synthetic cannabinoids use

AU - Solimini, R.

AU - Busardò, F. P.

AU - Rotolo, M. C.

AU - Ricci, Serafino

AU - Mastrobattista, L.

AU - Mortali, C.

AU - Graziano, S.

AU - Pellegrini, M.

AU - Di Luca, N. M.

AU - Palmi, Ilaria

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Synthetic cannabinoids (SCs) are psychotropic compounds, chemically created in laboratory to mimic cannabinergic brain activity of delta-9 tetrahydrocannabinol.The consumption of these compounds for recreational purposes can lead to a variety of adverse effects on health including overdose and deaths. Increasingly popular as substances of abuse since the 2000s, SCs were produced initially to bind and study cannabinoid receptors (they also can be called synthetic cannabimimetics) failing in eliminating the psychoactive effects. Currently, SCs are misused by students and young adults as "natural products" because of their herbal aspect. Actually, these apparently innocuous recreational substances hide toxic effects to health. Reported side effects are cardiovascular, gastrointestinal, neurological, renal, metabolic, ophthalmologic, pulmonary and psychoactive including dependence and withdrawal. A few cases of SCs ingestion have also been associated with liver failure.We herein review the recent literature on the SCs toxicity with particular attention to liver damage aspects.

AB - Synthetic cannabinoids (SCs) are psychotropic compounds, chemically created in laboratory to mimic cannabinergic brain activity of delta-9 tetrahydrocannabinol.The consumption of these compounds for recreational purposes can lead to a variety of adverse effects on health including overdose and deaths. Increasingly popular as substances of abuse since the 2000s, SCs were produced initially to bind and study cannabinoid receptors (they also can be called synthetic cannabimimetics) failing in eliminating the psychoactive effects. Currently, SCs are misused by students and young adults as "natural products" because of their herbal aspect. Actually, these apparently innocuous recreational substances hide toxic effects to health. Reported side effects are cardiovascular, gastrointestinal, neurological, renal, metabolic, ophthalmologic, pulmonary and psychoactive including dependence and withdrawal. A few cases of SCs ingestion have also been associated with liver failure.We herein review the recent literature on the SCs toxicity with particular attention to liver damage aspects.

KW - Hepatotoxicity

KW - Illicit use

KW - Synthetic cannabinoids

UR - http://www.scopus.com/inward/record.url?scp=85018308521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018308521&partnerID=8YFLogxK

M3 - Article

C2 - 28379600

AN - SCOPUS:85018308521

VL - 21

SP - 1

EP - 6

JO - European Review for Medical and Pharmacological Sciences

JF - European Review for Medical and Pharmacological Sciences

SN - 1128-3602

IS - 1

ER -